BioStem Technologies, Inc. (BSEM)
OTCMKTS
· Delayed Price · Currency is USD
12.65
-0.17 (-1.36%)
Dec 27, 2024, 4:00 PM EST
BioStem Technologies Revenue
BioStem Technologies had revenue of $82.56M in the quarter ending September 30, 2024, with 2,258.93% growth. This brings the company's revenue in the last twelve months to $210.49M, up 3,445.26% year-over-year. In the year 2023, BioStem Technologies had annual revenue of $16.69M with 142.69% growth.
Revenue (ttm)
210.49M
Revenue Growth
+3,445.26%
P/S Ratio
0.97
Revenue / Employee
6.38M
Employees
33
Market Cap
210.23M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 16.69M | 9.81M | 142.69% |
| Dec 31, 2022 | 6.88M | 2.53M | 58.38% |
| Dec 31, 2021 | 4.34M | 4.03M | 1,284.88% |
| Dec 31, 2017 | 313.45K | -293.78K | -48.38% |
| Dec 31, 2016 | 607.22K | 455.69K | 300.71% |
| Dec 31, 2015 | Pro | Pro | Pro |
| Dec 31, 2014 | Pro | Pro | Pro |
| Dec 31, 2011 | Pro | Pro | Pro |
| Dec 31, 2010 | Pro | Pro | Pro |
| Dec 31, 2009 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sandoz Group AG | 10.11B |
| Telix Pharmaceuticals Limited | 430.80M |
| Elekta AB (publ) | 1.66B |
| Ryman Healthcare Limited | 458.44M |
| Verano Holdings Corp. | 897.57M |
| Medexus Pharmaceuticals Inc. | 104.76M |
BioStem Technologies News
- 4 weeks ago - BioStem Announces Notice of Allowance for U.S. Patent Application for Sterile Human Placental Allografts - GlobeNewsWire
- 5 weeks ago - BioStem Technologies Signs Letter of Intent to Acquire Wound Care Products and Technologies from ProgenaCare Global - GlobeNewsWire
- 6 weeks ago - Long-Term, BioStem Technologies Still A Promising Growth Stock - Seeking Alpha
- 6 weeks ago - BioStem Technologies, Inc. (BSEM) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 2 months ago - BioStem Technologies Initiates Nationwide Launch of Vendaje AC® with Venture Medical Following Established Reimbursement in All Medicare Administrative Contractor (MAC) Regions - GlobeNewsWire
- 2 months ago - BioStem Technologies to Present at the LD Micro Main Event XVII on Wednesday, October 30, 2024, at 9:30 AM PT - Newsfile Corp
- 4 months ago - BioStem Technologies, Inc. to Present at the H.C. Wainwright 26th Annual Global Investment Conference in New York on September 9th at 3:30 PM ET - GlobeNewsWire
- 4 months ago - BioStem Technologies: A New Growth Star In Health Care - Seeking Alpha